Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination.
astrocytes
cholesterol
cytokines
myelin
oligodendrocyte
Journal
Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
13
03
2020
revised:
20
05
2020
accepted:
12
06
2020
pubmed:
1
7
2020
medline:
5
5
2021
entrez:
1
7
2020
Statut:
ppublish
Résumé
Remyelination is a regenerative process that is essential to recover saltatory conduction and to prevent neurodegeneration upon demyelination. The formation of new myelin involves the differentiation of oligodendrocyte progenitor cells (OPCs) toward oligodendrocytes and requires high amounts of cholesterol. Astrocytes (ASTRs) modulate remyelination by supplying lipids to oligodendrocytes. Remarkably, remyelination is more efficient in grey matter (GM) than in white matter (WM), which may relate to regional differences in ASTR subtype. Here, we show that a feeding layer of gmASTRs was more supportive to in vitro myelination than a feeding layer of wmASTRs. While conditioned medium from both gmASTRs and wmASTRs accelerated gmOPC differentiation, wmOPC differentiation is enhanced by secreted factors from gmASTRs, but not wmASTRs. In vitro analyses revealed that gmASTRs secreted more cholesterol than wmASTRs. Cholesterol efflux from both ASTR types was reduced upon exposure to pro-inflammatory cytokines, which was mediated via cholesterol transporter ABCA1, but not ABCG1, and correlated with a minor reduction of myelin membrane formation by oligodendrocytes. Surprisingly, a wmASTR knockdown of Fdft1 encoding for squalene synthase (SQS), an enzyme essential for the first committed step in cholesterol biosynthesis, enhanced in vitro myelination. Reduced secretion of interleukin-1β likely by enhanced isoprenylation, and increased unsaturated fatty acid synthesis, both pathways upstream of SQS, likely masked the effect of reduced levels of ASTR-derived cholesterol. Hence, our findings indicate that gmASTRs export more cholesterol and are more supportive to myelination than wmASTRs, but specific inhibition of cholesterol biosynthesis in ASTRs is beneficial for wmASTR-mediated modulation of myelination.
Identifiants
pubmed: 32602556
doi: 10.1111/jnc.15113
pmc: PMC7984098
doi:
Substances chimiques
Inflammation Mediators
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
624-641Informations de copyright
© 2020 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
Références
Ann Neurol. 2001 Sep;50(3):389-400
pubmed: 11558796
Int J Dev Neurosci. 2004 Apr;22(2):73-86
pubmed: 15036382
Ann Neurol. 2012 Dec;72(6):918-26
pubmed: 23076662
Curr Drug Targets. 2005 May;6(3):301-23
pubmed: 15857290
Neurosci Lett. 2003 Mar 13;339(1):62-6
pubmed: 12618301
Exp Neurol. 2014 Jan;251:39-46
pubmed: 24200549
J Lipid Res. 1978 Nov;19(8):1068-70
pubmed: 731127
Nat Neurosci. 2013 Oct;16(10):1370-2
pubmed: 23995069
J Neuropathol Exp Neurol. 2017 May 1;76(5):390-401
pubmed: 28521040
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
J Biol Chem. 2006 Feb 17;281(7):4049-57
pubmed: 16352604
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E302-E309
pubmed: 29279367
J Lipid Res. 1997 Aug;38(8):1620-9
pubmed: 9300784
Ann N Y Acad Sci. 2015 Sep;1351:99-113
pubmed: 26200258
Glia. 2016 Apr;64(4):583-602
pubmed: 26678483
J Neurosci. 2015 Jan 7;35(1):4-20
pubmed: 25568099
Glia. 2008 May;56(7):750-63
pubmed: 18293402
Eur Cytokine Netw. 2009 Sep;20(3):112-20
pubmed: 19825520
Dev Neurosci. 2006;28(3):196-208
pubmed: 16679766
Lancet. 2008 Oct 25;372(9648):1502-17
pubmed: 18970977
FASEB J. 2012 Oct;26(10):4302-15
pubmed: 22751013
J Neurosci. 2008 Dec 10;28(50):13609-14
pubmed: 19074034
J Anat. 2011 Jul;219(1):44-52
pubmed: 21496013
Bioessays. 2003 Jan;25(1):72-8
pubmed: 12508285
J Neurosci. 2017 Oct 11;37(41):9925-9938
pubmed: 28899916
PLoS Biol. 2017 May 26;15(5):e1002605
pubmed: 28549068
J Neurosci Res. 2012 Feb;90(2):388-98
pubmed: 21971760
J Neurosci. 2008 Jan 2;28(1):264-78
pubmed: 18171944
J Biol Chem. 2016 Nov 18;291(47):24641-24656
pubmed: 27703009
Cold Spring Harb Perspect Biol. 2014 Nov 20;7(1):a020362
pubmed: 25414368
J Steroid Biochem Mol Biol. 2000 Apr;72(5):169-95
pubmed: 10822008
EMBO J. 2002 Apr 15;21(8):1957-66
pubmed: 11953315
Nat Rev Neurosci. 2008 Nov;9(11):839-55
pubmed: 18931697
Science. 2018 Feb 9;359(6376):684-688
pubmed: 29301957
Sci Rep. 2018 Feb 1;8(1):2113
pubmed: 29391408
Science. 2012 Jul 20;337(6092):358-62
pubmed: 22745251
J Neurochem. 2009 Mar;108(6):1442-52
pubmed: 19222709
Mol Med. 2010 Sep-Oct;16(9-10):438-49
pubmed: 20485864
Nature. 2012 Apr 29;485(7399):517-21
pubmed: 22622581
Front Cell Neurosci. 2014 Mar 13;8:73
pubmed: 24659953
Exp Neurol. 2016 Sep;283(Pt A):330-40
pubmed: 27384502
Am J Pathol. 2009 May;174(5):1880-90
pubmed: 19349355
Cell Mol Life Sci. 2008 Sep;65(17):2702-20
pubmed: 18516496
Glia. 2012 May;60(6):919-35
pubmed: 22431161
Front Cell Neurosci. 2015 Mar 20;9:76
pubmed: 25852472
Nat Neurosci. 2005 Apr;8(4):468-75
pubmed: 15793579
J Neurosci Res. 2020 Jul;98(7):1370-1397
pubmed: 31965607
J Lipid Res. 2004 Aug;45(8):1375-97
pubmed: 15254070
Traffic. 2008 Nov;9(11):1839-49
pubmed: 18647169
Nat Commun. 2017 Jan 24;8:14241
pubmed: 28117328
Brain. 2013 Jan;136(Pt 1):116-31
pubmed: 23365094
Methods Mol Biol. 2012;814:23-45
pubmed: 22144298
J Neurochem. 2021 Mar;156(5):624-641
pubmed: 32602556
J Atheroscler Thromb. 2011;18(6):513-30
pubmed: 21636950
Nat Rev Endocrinol. 2017 Dec;13(12):710-730
pubmed: 28849786
Biochem Biophys Res Commun. 2004 Jul 30;320(3):860-7
pubmed: 15240127
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
Neuropathol Appl Neurobiol. 1999 Jun;25(3):207-14
pubmed: 10417662
Int J Neurosci. 2005 Sep;115(9):1333-43
pubmed: 16048809
Glia. 2012 Oct;60(10):1468-80
pubmed: 22689449
Brain. 2008 Jun;131(Pt 6):1464-77
pubmed: 18490361
Nature. 2012 Jul 26;487(7408):443-8
pubmed: 22801498
Mol Cell Neurosci. 2002 Jul;20(3):489-502
pubmed: 12139924
Cancer Res. 1990 Sep 15;50(18):5751-5
pubmed: 2393849
Proc Natl Acad Sci U S A. 2019 May 14;116(20):10130-10139
pubmed: 31040210
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
Brain Res Rev. 2010 May;63(1-2):2-10
pubmed: 20005253
Acta Neuropathol Commun. 2019 Aug 12;7(1):130
pubmed: 31405387
Nat Rev Drug Discov. 2017 Sep;16(9):617-634
pubmed: 28685761
Cell Physiol Biochem. 2016;39(6):2110-2120
pubmed: 27802439
J Neurochem. 2009 Apr;109(1):125-34
pubmed: 19166509
Anal Biochem. 2013 Jul 15;438(2):133-5
pubmed: 23541521
Vascul Pharmacol. 2007 Feb;46(2):91-6
pubmed: 16942919
Ann Neurol. 2012 Sep;72(3):419-32
pubmed: 23034914
J Biol Chem. 1998 Dec 25;273(52):35299-306
pubmed: 9857071
Biochim Biophys Acta. 2013 Feb;1831(2):263-75
pubmed: 23010475
Nucleic Acids Res. 2009 Apr;37(6):e45
pubmed: 19237396
Neuroscience. 2014 Sep 12;276:161-73
pubmed: 24231735